Key result
Lower daytime SpO2 and higher BMI are linked to worse sleep-disordered breathing in cardiovascular patients.
Why the study?
Sleep-disordered breathing links to various cardiovascular diseases, but comprehensive insights and detailed profiles remain scarce.
Cohort (n=5,765)
No
Low daytime SpO2 and elevated BMI can effectively predict severe sleep-disordered breathing in patients with cardiovascular diseases, suggesting a simple method to identify patients needing intervention.
Answers are grounded in this paper and cite their sources.
May support targeted SDB screening in CVD patients with low SpO2 or high BMI; leaves open prospective validation before practice change.
Sleep-disordered breathing (SDB) links to various cardiovascular diseases (CVDs), but comprehensive insights and detailed profiles remain scarce. This study examined the clinical characteristics of CVD patients complicated by SDB in the enrolled all consecutive 5765 patients who underwent screening tests for SDB during hospitalization from January 2014 to December 2019, using the database of Cardiovascular Medicine, Kurume University Hospital. Desaturation during sleep in SDB was significantly worse in terms of age, sex, daytime resting oxygen saturation (SpO2), systolic blood pressure (SBP), pulse pressure, body mass index (BMI), white blood cell count, hemoglobin A1c, serum creatinine, N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiothoracic ratio on chest X-ray, and left ventricular ejection fraction on echocardiography (all p-values < 0.001, except for SBP p = 0.002, and NT-proBNP p = 0.004). Coronary artery disease and heart failure, but not pulmonary hypertension, were associated with a higher prevalence and a greater risk of moderate to severe SDB, typically in older patients. Notably, low SpO2 during daytime and elevated BMI were indicative of SDB across all age categories for both sexes. Heatmaps of daytime SpO2 and BMI can effectively predict the severe SDB in patients with CVDs, suggesting the potential for efficient therapeutic interventions for SDB.
No takes yet. Share an insight, caveat, or question.
Shimozono et al. (2025) conducted a cohort in Cardiovascular diseases (n=5,765). Sleep-disordered breathing (SDB) vs. No SDB was evaluated on SpO2 at awakening across SDB severity groups (p=<0.001). In patients with cardiovascular diseases, lower daytime oxygen saturation and elevated body mass index were significantly associated with more severe sleep-disordered breathing.
Synapse has enriched 10 related papers. Consider them for comparative context: